Menu
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations.

Ascend, Xellia Announce Refunds for 340B Overcharges

Bella Czajkowski, National Correspondent 340B Report Views
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Column: Much-Needed Wins for 340B Providers but Challenges Could Be Lurking

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live